Tbk1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TBK1 (TANK-Binding Kinase 1) is a serine/threonine kinase involved in innate immunity, autophagy, and cell survival. TBK1 mutations cause familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), making it a critical gene in understanding neurodegenerative disease mechanisms.
[^2]
[^3]
[^4]
[^5]
[^6]
[^7]
| Gene Symbol | TBK1 |
| Full Name | TANK-Binding Kinase 1 |
| Chromosomal Location | 12q14.1 |
| NCBI Gene ID | 29142 |
| OMIM ID | 604834 |
| Ensembl ID | ENSG00000183735 |
| UniProt ID | Q9UHD2 |
| Protein | [TBK1 Protein](/proteins/tbk1-protein) |
The TBK1 gene spans approximately 58 kb on chromosome 12 and contains 21 exons. It encodes a 729-amino acid serine/threonine kinase with multiple functional domains:
- Kinase Domain (KD): Residues 1-307, catalyzes phosphorylation
- UBAN Domain: Ubiquitin-binding domain for substrate recognition
- Coiled-Coil Domain (CC): mediates protein-protein interactions
- LRR Domain: Leucine-rich repeat for regulatory functions
- Brain: Widely expressed in neurons, astrocytes, and microglia
- Spinal Cord: High expression in motor neurons
- Peripheral Tissues: Heart, lung, liver, kidney
TBK1 is a serine/threonine kinase with critical roles in multiple cellular pathways:
- NF-κB Activation: Phosphorylates IKKε, activates NF-κB signaling
- Type I IFN Response: Essential for IRF3/IRF7 phosphorylation and interferon production
- TLR Signaling: Involved in Toll-like receptor signaling cascades
- Autophagosome Formation: Phosphorylates essential autophagy receptors
- Selective Autophagy: Mediates clearance of pathogens and damaged organelles
- Mitophagy: PINK1/Parkin-independent mitophagy pathway
- Xenophagy: Intracellular pathogen clearance
- Pro-survival Signaling: NF-κB-mediated anti-apoptotic gene expression
- Metabolic Regulation: Links nutrient sensing to autophagy
TBK1 is a major ALS risk gene:
- Frequency: ~1% of ALS cases carry TBK1 mutations
- Inheritance: Autosomal dominant with incomplete penetrance
- Mechanism: Haploinsufficiency (loss-of-function mutations)
- Phenotype: Typical ALS presentation with possible FTD overlap
- Onset: Typically adult-onset (40-70 years)
- FTD-ALS Spectrum: TBK1 mutations cause combined FTD/ALS
- Clinical Features: Behavioral variant FTD, language FTD
- Pathology: TDP-43 proteinopathy
- Overlap: Up to 50% of TBK1 mutation carriers develop FTD
- Susceptibility: TBK1 deficiency impairs IFN response to HSV-1
- Recurrent Encephalitis: Some patients with TBK1 mutations develop HSE
- Systemic Lupus Erythematosus: TBK1 polymorphisms associated with SLE risk
- Rheumatoid Arthritis: Genetic links identified
TBK1 mutations impair autophagic clearance of:
- Protein Aggregates: Reduced clearance of TDP-43, SOD1 aggregates
- Damaged Mitochondria: Impaired mitophagy leads to ROS accumulation
- Axonal Organelles: Defective axonal autophagy
- Microglial Dysfunction: Impaired innate immune signaling
- Cytokine Production: Altered inflammatory responses
- T-cell Activation: Modified neuroinflammation
- Synaptic Homeostasis: Autophagy-dependent synaptic maintenance
- Neuromuscular Junction: Defects in presynaptic function
| Drug/Approach |
Mechanism |
Status |
Application |
| TBK1 Inhibitors |
Kinase blockade |
Preclinical |
Cancer, autoimmunity |
| Autophagy Enhancers |
Bypass TBK1 function |
Research |
ALS/FTD |
| Gene Therapy |
Deliver wild-type TBK1 |
Preclinical |
Potential |
| Antisense Oligonucleotides |
Reduce toxic transcripts |
Research |
ALS |
- Essential Function: TBK1 is essential for innate immunity
- BBB Penetration: CNS-deliverable compounds needed
- Heterozygous Dosing: Therapeutic window for haploinsufficiency
- Small Molecule Activators: Develop autophagy-inducing compounds
- Viral Vector Delivery: AAV-mediated TBK1 expression
- Biomarkers: Develop TBK1 activity biomarkers
The study of Tbk1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.